ISRCTN78466206已完成未知
The quality of life of multiple sclerosis patients in Europe
Erasmus School of Health Policy & Management0 个研究点目标入组 182 人开始时间: 2019年8月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 182
研究概览
简要总结
2021 results in https://doi.org/10.1186/s13690-021-00561-z (added 14/04/2021) (published 20/03/2021)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Patients diagnosed with clinically definite multiple sclerosis (relapsing-remitting MS, secondary progressive MS, primary progressive MS)
- •2. Age 18 years or older
- •3. No restrictions whether patients are or are not using immunomodulatory therapy, or have used other therapies in the past
- •4. Participants have to have access to internet and the OPTOGENERAPY website to fill in the online questionnaire
排除标准
- •Patients with a co-morbidity that negatively influences their cognition (for example dementia, stroke)
研究者
相似试验
尚未招募
不适用
Enhancing Quality of Life in MS Patients Through Tailored Therapeutic EducationMultiple Sclerosis (MS)NCT06450600Akhrif Iman50
尚未招募
不适用
Sleep and Quality of Life in Multiple SclerosisG35.9G47.9F32.9G93.3Sleep disorder, unspecifiedDepressive episode, unspecifiedPostviral fatigue syndromeDRKS00004970niversitätsklinikum Jena2,100
已完成
不适用
Tolerability and Quality of Life Study in Participants Who Switched to Avonex PenRelapsing-Remitting Multiple SclerosisClinical Isolated Syndrome (CIS)Multiple SclerosisNCT02076841Biogen40
已完成
不适用
A Telemedicine Mindfulness-based Intervention for People With Multiple Sclerosis and Their CaregiversMultiple SclerosisNCT02364505Fondazione Don Carlo Gnocchi Onlus156
已完成
不适用
Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)Multiple SclerosisNCT00439257US Department of Veterans Affairs124